Press release
Cancer Biomarker Market Analysis Highlights Growth To $52.63 Billion By 2030 At 16% CAGR
Cancer Biomarker Market
Projected Growth of the Cancer Biomarker Market by 2030
The global cancer biomarker market is forecasted to surge to $52.63 billion by 2030, growing at a robust compound annual growth rate (CAGR) of 16.0%. This impressive growth is fueled by the rising demand for tailored cancer therapies, expanding investments in precision medicine, and the increasing development of biomarker-driven drugs. Additionally, the integration of AI-based biomarker analyses and the emphasis on early cancer screening methods are critical factors supporting market expansion. Key trends anticipated to influence the market include greater utilization of genetic and protein biomarkers, widespread adoption of companion diagnostic tools, enhanced incorporation of omics technologies, broadening applications of liquid biopsies, and a strengthened focus on early-stage cancer detection.
Download a free sample of the cancer biomarker market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8492&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Leading Companies Driving the Cancer Biomarker Industry
Several prominent organizations dominate the cancer biomarker market, including F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., QIAGEN NV, Illumina Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, bioMérieux SA, Becton dic*kinson and Company, Merck & Co. Inc., Bristol-Myers Squibb Company, PerkinElmer Inc., Siemens AG, Exact Sciences Corporation, Novartis AG, Agilent Technologies Inc., Hologic Inc., Myriad Genetics Inc., Foundation Medicine Inc., Guardant Health Inc., Natera Inc., Sysmex Corporation, Biocartis Group NV, NanoString Technologies Inc., Veracyte Inc., Epic Sciences Inc., Cynvenio Biosystems Inc., Genomic Health Inc., Oncocyte Corporation, Exosome Diagnostics Inc., and Grail Inc.
Significant Acquisition to Strengthen Multi-Omics Capabilities
In June 2025, Illumina Inc., a U.S.-based leader in genomics and sequencing technology, acquired SomaLogic Inc. for $350 million, with potential additional payments up to $75 million based on performance milestones. This strategic acquisition aims to accelerate Illumina's multi-omics strategy by integrating high-throughput proteomics capabilities into its sequencing platforms. SomaLogic, a clinical diagnostics company specializing in proteomics, has developed the powerful SomaScan platform, which enables comprehensive protein-biomarker discovery for disease profiling and research.
View the full cancer biomarker market report:
https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Innovations Shaping the Future of Cancer Biomarker Market
Top companies in this space are concentrating on breakthrough solutions like AI-powered cancer biomarkers to improve diagnostic precision and customize treatment approaches. AI-driven biomarkers use artificial intelligence to identify and analyze cancer-related biological indicators. For example, in September 2023, U.S.-based Ibex Medical Analytics introduced Galen Breast HER2, an AI-powered tool designed to boost the accuracy and reproducibility of HER2 scoring in breast cancer patients. This platform assists pathologists by automatically detecting invasive tumor regions and quantifying HER2 expression according to the 2018 ASCO/CAP guidelines. Utilizing a novel computational approach to analyze immunohistochemistry (IHC)-stained slides, Galen Breast HER2 offers detailed visualizations of staining patterns, thereby helping clinicians make well-informed treatment decisions.
Detailed Insights into Cancer Biomarker Market Segments
The cancer biomarker market is segmented comprehensively as follows:
1) By Biomarker Type: Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types
2) By Profiling Technologies: Omics Technologies, Immunoassay, Bioinformatics, Cytogenetics
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers
4) By Application: Diagnostics, Research and Development, Prognostics, Risk Assessment, Other Applications
Further subsegments include:
- Protein Biomarkers: Tumor-Specific Antigens and Circulating Tumor Proteins
- Genetic Biomarkers: DNA Mutations and RNA Expression Profiles
- Other Biomarker Types: Epigenetic and Metabolomic Biomarkers
This detailed segmentation allows for nuanced analysis and understanding of the market's diverse components, supporting targeted development and investment strategies.
Our 2026 market reports now include enhanced strategic insights through:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarker Market Analysis Highlights Growth To $52.63 Billion By 2030 At 16% CAGR here
News-ID: 4569412 • Views: …
More Releases from The Business Research Company
Continuous Glucose Monitoring Devices Market Demonstrates Long-Term Growth Poten …
The continuous glucose monitoring devices market is on the verge of significant expansion, driven by technological advances and changing healthcare needs. With innovations aimed at improving diabetes management and patient convenience, this industry is set to experience notable growth over the coming years. Here's an in-depth look at the market's size, key players, trends, and segment breakdowns shaping its future.
Steady Growth Projections in the Continuous Glucose Monitoring Devices Market …
Capsule Endoscopy System Market Report Provides Insights Into Market Evolution A …
The capsule endoscopy system market is poised for significant expansion in the coming years, driven by advances in technology and increasing demand for precise gastrointestinal diagnostics. As healthcare providers seek more effective, patient-friendly tools for detecting GI conditions, this sector is expected to witness robust growth and innovation. Let's explore the market's size, key players, emerging trends, and segment breakdown to understand its future trajectory.
Market Growth Expectations and Key Drivers…
Cranial Fixation And Stabilization Devices Market Study Explores Industry Growth …
The cranial fixation and stabilization devices market is on the path to significant expansion in the coming years, driven by advancements in neurosurgical techniques and growing healthcare infrastructure. As patient safety and surgical precision become paramount, this sector is set to see noteworthy developments that will shape its future landscape. Let's explore the market size, key players, prevailing trends, and segmentation details that define this industry.
Projected Market Size and Growth…
Continuous Blood Glucose Monitoring Market Outlook Signals Expansion To $26.11 B …
The continuous blood glucose monitoring market is on the cusp of significant expansion, driven by technological advancements and increasing demand for effective diabetes management tools. This sector is evolving rapidly with innovations that enhance patient convenience and offer more precise glucose tracking. Below is an overview of the market size projections, key players, emerging trends, and segment-wise outlook that define the current and future landscape of continuous blood glucose monitoring.
Projected…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
